A share price of Pfizer Inc [PFE] is currently trading at $24.9, down -0.36%. An important factor to consider is whether the stock is rising or falling in short-term value. The PFE shares have gain 0.08% over the last week, with a monthly amount drifted -1.46%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Scotiabank started tracking the stock with Sector Outperform rating on November 13, 2025, and set its price target to $30. On April 22, 2025, Cantor Fitzgerald initiated with a Neutral rating and assigned a price target of $24 on the stock. Wolfe Research initiated its recommendation with an Underperform and recommended $25 as its price target on November 15, 2024. In a note dated October 17, 2024, Bernstein initiated an Mkt Perform rating and provided a target price of $32 on this stock.
Pfizer Inc experienced fluctuations in its stock price throughout the past year between $20.92 and $27.69. Currently, Wall Street analysts expect the stock to reach $28.57 within the next 12 months. Pfizer Inc [NYSE: PFE] shares were valued at $24.9 at the most recent close of the market. An investor can expect a potential return of 14.74% based on the average PFE price forecast.
Analyzing the PFE fundamentals
Trailing Twelve Months sales for Pfizer Inc [NYSE:PFE] were 62.78B which represents -5.92% decline. Gross Profit Margin for this corporation currently stands at 0.71% with Operating Profit Margin at 0.28%, Pretax Profit Margin comes in at 0.15%, and Net Profit Margin reading is 0.16%. To continue investigating profitability, this company’s Return on Assets is posted at 0.05, Equity is 0.11 and Total Capital is 0.1. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.66.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 24.85 points at the first support level, and at 24.79 for the second support level. However, for the 1st resistance point, the stock is sitting at 24.99, and for the 2nd resistance point, it is at 25.07.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Pfizer Inc [NYSE:PFE] is 1.28. On the other hand, the Quick Ratio is 0.97, and the Cash Ratio is 0.04. Considering the valuation of this stock, the price to sales ratio is 2.25, the price to book ratio is 1.53 and price to earnings (TTM) ratio is 14.51.
Transactions by insiders
Recent insider trading involved Dolsten Mikael, Former Officer, that happened on May 23 ’25 when 59781.0 shares were purchased. Former Officer, Dolsten Mikael completed a deal on May 05 ’25 to buy 55000.0 shares. Meanwhile, SVP & Controller DAMICO JENNIFER B. sold 2500.0 shares on Mar 04 ’25.
